Generic Name :Paclitaxel Indications Ovarian Carcinoma: Xelpac is indicated as first line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As first line therapy, Xelpac is indicated in combination with cisplatin. Breast Carcinoma: Xelpac is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy. […]